Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2024 Earnings Call Transcript February 26, 2025
Corcept Therapeutics Incorporated misses on earnings expectations. Reported EPS is $0.26 EPS, expectations were $0.37.
Operator: Thank you for standing by, and welcome to Corcept Therapeutics conference call. [Operator Instructions] I would now like to hand the call over to Atabak Mokari, CFO. Please go ahead.
Atabak Mokari: Hello, everyone. Good afternoon, and thank you for joining us. Today,...
